Premium
FS04.6
Dose/unit area and time – key factors influencing the elicitation capacity of MCI/MI
Author(s) -
Zachariae Claus,
Sørensen A,
McNamee P,
Grey J,
Wooder M,
Menné T
Publication year - 2004
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/j.0105-1873.2004.0309ao.x
Subject(s) - medicine , placebo , allergy , nuclear medicine , pathology , immunology , alternative medicine
The objective of the study was to investigate, using the Repeated Open Application Test (ROAT), two key parameters of exposure – allergen concentration (dose/unit area) and time in terms of the elicitation capacity of methylchloroisothiazolinone and methylisothiazolinone (MCI/MI) in MCI/MI‐sensitised individuals and to explore the inter‐relationship between these two key factors. The study was designed as a double‐blind, placebo‐controlled, dose‐response ROAT preceded by a Diagnostic Patch Test (DPT). 79 patients with a known MCI/M allergy were contacted, 29 were diagnostically patch tested and 25 had their allergy confirmed. 25 MCI/M‐allergic subjects and 10 healthy non‐allergic control subjects were challenged with 2 ppm of MCI/MI/unit area of skin for 4 weeks. After a wash out period of at least 4 weeks the subjects were challenged with 7.5 ppm of MCI/MI/unit area of skin for 4 weeks. A ROAT with 2 drops of solution twice a day was conducted on the volar aspect of the left and right forearms on a 3 × 3 cm area resulting in dose/unit area of MCI/MI of 0.025 mg/cm 2 and 0.095 mg/cm 2 for 2 ppm and 7,5 ppm MCI/MI respectively. The elicitation capacity of MCI/MI in MCI/MI sensitive patients is dependent on the exposure dose/unit area and time The results of this study will be a useful addition to the risk assessment information available for MCI/MI. The risk assessment for the use of MCI/MI in rinse off consumer products is unaffected by the results of this study.